These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26260701)

  • 1. Brachytherapy: state-of-the-art radiotherapy in prostate cancer.
    Chao MW; Grimm P; Yaxley J; Jagavkar R; Ng M; Lawrentschuk N
    BJU Int; 2015 Oct; 116 Suppl 3():80-8. PubMed ID: 26260701
    [No Abstract]   [Full Text] [Related]  

  • 2. Early quality of life outcomes in patients with prostate cancer managed by high-dose-rate brachytherapy as monotherapy.
    Komiya A; Fujiuchi Y; Ito T; Morii A; Yasuda K; Watanabe A; Nozaki T; Iida H; Nomura K; Fuse H
    Int J Urol; 2013 Feb; 20(2):185-92. PubMed ID: 22905941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life after single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for prostate cancer.
    Morton GC; Loblaw DA; Chung H; Tsang G; Sankreacha R; Deabreu A; Zhang L; Mamedov A; Cheung P; Batchelar D; Danjoux C; Szumacher E
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1299-305. PubMed ID: 20708853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State-of-the-art: prostate LDR brachytherapy.
    Voulgaris S; Nobes JP; Laing RW; Langley SE
    Prostate Cancer Prostatic Dis; 2008; 11(3):237-40. PubMed ID: 18364676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life.
    Morton GC; Loblaw DA; Sankreacha R; Deabreu A; Zhang L; Mamedov A; Cheung P; Keller B; Danjoux C; Szumacher E; Thomas G
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):811-7. PubMed ID: 19836166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage external beam radiotherapy for prostate cancer after radical prostatectomy: current status and controversy.
    Raldow A; Hamstra DA; Kim S; Yu JB
    Oncology (Williston Park); 2010 Jul; 24(8):692-700, 702. PubMed ID: 20718248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: a Phase II trial.
    Barkati M; Williams SG; Foroudi F; Tai KH; Chander S; van Dyk S; See A; Duchesne GM
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1889-96. PubMed ID: 21550182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is high dose rate brachytherapy reliable and effective treatment for prostate cancer patients? A review of the literature.
    De Bari B; Daidone A; Alongi F
    Crit Rev Oncol Hematol; 2015 Jun; 94(3):360-70. PubMed ID: 25819287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term results.
    Mahal BA; Ziehr DR; Hyatt AS; Neubauer-Sugar EH; O'Farrell DA; O'Leary MP; Steele GS; Niedermayr TR; Beard CJ; Martin NE; Orio PF; D'Amico AV; Devlin PM; Nguyen PL
    Brachytherapy; 2014; 13(5):442-9. PubMed ID: 24880584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry.
    Van Gellekom MP; Moerland MA; Van Vulpen M; Wijrdeman HK; Battermann JJ
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):772-80. PubMed ID: 15964707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of high dose rate brachytherapy in combination with external beam radiotherapy on men's health-related quality of life and sexual function over a 2 year time span.
    Conaglen HM; de Jong D; Hartopeanu C; Conaglen JV; Tyrie LK
    Clin Oncol (R Coll Radiol); 2013 Mar; 25(3):197-204. PubMed ID: 23183305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcomes and quality-of-life issues for patients treated with prostate brachytherapy.
    Abel L; Dafoe-Lambie J; Butler WM; Merrick GS
    Clin J Oncol Nurs; 2003; 7(1):48-54. PubMed ID: 12629934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising long-term health-related quality of life after high-dose-rate brachytherapy boost for localized prostate cancer.
    Wahlgren T; Nilsson S; Lennernäs B; Brandberg Y
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):662-70. PubMed ID: 17499452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life after radical radiotherapy for prostate cancer: longitudinal study from a randomised trial of external beam radiotherapy alone or in combination with high dose rate brachytherapy.
    Hoskin PJ; Rojas AM; Ostler PJ; Hughes R; Lowe GJ; Bryant L
    Clin Oncol (R Coll Radiol); 2013 May; 25(5):321-7. PubMed ID: 23384799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?
    Zaorsky NG; Doyle LA; Hurwitz MD; Dicker AP; Den RB
    Expert Rev Anticancer Ther; 2014 Jan; 14(1):39-50. PubMed ID: 24124755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.
    Forsythe K; Blacksburg S; Stone N; Stock RG
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):630-5. PubMed ID: 22099032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?
    Morton G; Loblaw A; Cheung P; Szumacher E; Chahal M; Danjoux C; Chung HT; Deabreu A; Mamedov A; Zhang L; Sankreacha R; Vigneault E; Springer C
    Radiother Oncol; 2011 Sep; 100(3):463-7. PubMed ID: 21924511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute adverse effects of high dose brachytherapy in combination with external radiotherapy in localized prostate cancer].
    Soumarová R; Homola L; Stursa M; Perková H
    Cas Lek Cesk; 2006; 145(1):43-9. PubMed ID: 16468241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of high-dose proton radiotherapy and brachytherapy in localized prostate cancer: a case-matched analysis.
    Coen JJ; Zietman AL; Rossi CJ; Grocela JA; Efstathiou JA; Yan Y; Shipley WU
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e25-31. PubMed ID: 21470787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.
    Ferrer M; Guedea F; Suárez JF; de Paula B; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Boladeras A; Ayala A; Craven-Bratle J; Ávila M; Cunillera O; Pardo Y; Alonso J; Aguiló F;
    Radiother Oncol; 2013 Aug; 108(2):306-13. PubMed ID: 23849168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.